 |
 |

Growth Hormone for "Antiaging"
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their Commentary, Dr Perls and colleagues1 present an important discussion of the misuse of HGH in the antiaging industry and emphasize its legal ramifications. The authors, however, neglected to mention an important legal use of HGH in adults. In 2004, the Food and Drug Administration (FDA) approved HGH as an orphan drug for patients with intestinal failure2 after a randomized, placebo-controlled, double-blind clinical trial showed benefits of HGH therapy for reduction of parenteral nutrition.3 Some patients, parenteral nutrition-dependent for many years, were even able to completely wean off parenteral nutrition. While there are a relatively small number of patients with intestinal failure or short gut, they tend to be very ill. Human growth hormone is the only growth factor or biological treatment approved with a positive long-term effect on intestinal rehabilitation.
Financial Disclosures: Dr Sauter is a member of the speaker's bureau for Serono, the manufacturer . . . [Full Text of this Article]
Bernhard Sauter, MD
bernhard.sauter@mssm.edu Mount Sinai School of Medicine New York, NY
RELATED ARTICLES
Growth Hormone for "Antiaging"
Thierry Hertoghe and Suzie Schuder
JAMA. 2006;295(8):888.
EXTRACT
| FULL TEXT
Growth Hormone for "Antiaging"
Claude Dalle and Vicario Claude
JAMA. 2006;295(8):889.
EXTRACT
| FULL TEXT
Growth Hormone for "Antiaging"Reply
Thomas Perls, Neal R. Reisman, and S. Jay Olshansky
JAMA. 2006;295(8):889-890.
EXTRACT
| FULL TEXT
Provision or Distribution of Growth Hormone for "Antiaging": Clinical and Legal Issues
Thomas T. Perls, Neal R. Reisman, and S. Jay Olshansky
JAMA. 2005;294(16):2086-2090.
EXTRACT
| FULL TEXT
|